Possibilities of the use Angiotensin converting enzyme inhibitor in peripheral arterial disease
Zagidullin, N.S.; Valeeva, K.F.; Zagidullin, S.Z.; Rezbaeva, A.G.
Kardiologiia 50(4): 92-96
2010
ISSN/ISBN: 0022-9040 PMID: 20459427 Document Number: 640751
Document emailed within 1 workday
Related Documents
Al-Omran, M.; Lindsay, T.F. 2005: Should all patients with peripheral arterial disease be treated with an angiotensin-converting enzyme inhibitor? Canadian Journal of Cardiology 21(2): 189-193Zapesochnaia, I.L.; Avtandilov, A.G. 2014: The influence of combined therapy with calcium antagonist and angiotensin-converting enzyme inhibitor on the circadian profile of arterial pressure in patients with arterial hypertension in the Far North Klinicheskaia Meditsina 92(10): 33-40
Britov, A.N.; Alamdarova, I.I.; Deev, A.D.; Orlov, A.A. 2003: Special features of clinical effects of an angiotensin converting enzyme inhibitor lisinopril in patients with arterial hypertension Kardiologiia 43(10): 66-71
Katel'nitskaia, L.I.; Ivanchenko, D.N.; Khansheva, L.A.; Kholoshina, L.V.; Glova, S.E.; Pleskachev, S.A. 2006: Advantages of long-term controlled stepwise therapy of arterial hypertension with the use of angiotensin converting enzyme inhibitor spirapril Kardiologiia 46(3): 35-38
Pavliukova, E.N.; Bakhmet'eva, T.A.; Puzyrev, K.V.; Karpov, R.S. 2006: Dynamics of left ventricular longitudinal function in patients with arterial hypertension during therapy with angiotensin converting enzyme inhibitor moexipril Kardiologiia 46(9): 19-25
Stanek, E.J.; Nara, A.R.; Strohl, K.P.; Nair, R.N.; Decker, M.J.; Munger, M.A. 1994: Effect of long-term angiotensin-converting enzyme inhibitor therapy on arterial oxygen saturation in patients with mild to moderate heart failure PharmacoTherapy 14(3): 321-329
Watanabe, Y.; Fukuzawa, Y.; Inaguma, D. 1996: Angiotensin converting enzyme inhibitor improves nephrotic syndrome associated with cyanotic congenital heart disease Clinical Nephrology 45(5): 362-363
Zhang, G.-h.; Hou, F.-f.; Zhang, X.; Liu, Q.-f. 2005: Can angiotensin-converting enzyme inhibitor be used in chronic kidney disease patients with serum creatinine level greater than 266 micromol/L? Zhonghua Nei Ke Za Zhi 44(8): 592-596
Iimura, O.; Kusano, E.; Tanba, K.; Yanagiba, S.; Amemiya, M.; Ando, Y.; Honma, S.; Muto, S.; Asano, Y. 2003: Additive antiproteinuric effect of angiotensin Ii receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis Nihon Jinzo Gakkai Shi 45(5): 439-444
Anantharaman, R.; Bhansali, A.; Bhadada, S.K.; Kohli, H.S.; Dutta, P.; Walia, R.; Jayaprakash, P.; Upreti, V. 2010: Anti-albuminuric efficacy of a combination of angiotensin converting enzyme inhibitor and angiotensin receptor blocker in type 1 DM with nephropathy Indian Journal of Medical Research 132: 42-47
Kono, T.; Ikeda, F.; Oseko, F.; Imura, H.; Endo, J. 1978: Angiotensin i converting enzyme inhibitor and angiotensin Ii antagonist Nihon Rinsho. Japanese Journal of Clinical Medicine 36(11): 3613-3620
Papadopoulos, D.P.; Economou, E.V.; Makris, T.K.; Kapetanios, K.J.; Moyssakis, I.; Votteas, V.E.; Toutouzas, P.K. 2004: Effect of angiotensin-converting enzyme inhibitor on collagenolytic enzyme activity in patients with acute myocardial infarction Drugs under Experimental and Clinical Research 30(2): 55-65
Jasik, M.; Zdrojewicz, Z.; Stawicki, S. 1999: The activity of renin-angiotensin-aldosterone system (RAA) and possibilities of application angiotensin converting enzyme inhibitors (ACE I) in selected diseases of endocrine glands Wiadomosci Lekarskie 52(3-4): 202-210
Antelava, N.A.; Gongadze, N.V.; Gogolauri, M.I.; Kezeli, T.D.; Pachkoriia, K.Z. 2007: Comparative characteristic of angiotensin-converting enzyme inhibitor--captopril and the angiotensin Ii receptor blokers--losartan action on the oxidative metabolism in experimental hyperlipidemia in rabbits Georgian Medical News 150: 57-60
Zhang, R.-y.; Huang, Y.-l.; Sun, Y.-h. 2005: Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase Zhonghua Yi Xue Za Zhi 85(15): 1053-1056
Diskin, C.J.; Stokes, T.J.; Dansby, L.M.; Radcliff, L.; Carter, T.B. 2007: Will the addition of pentoxifylline reduce proteinuria in patients with diabetic glomerulosclerosis refractory to maximal doses of both an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker? Journal of Nephrology 20(4): 410-416
Haghfelt, T. 1994: Trandolapril--a new angiotensin-converting enzyme inhibitor Ugeskrift for Laeger 156(42): 6232-6235
Dzau, V.I. 1989: Quinapril--a new angiotensin-converting enzyme inhibitor: an overview Angiology 40(4 Pt 2): 329-330
Bajaj, A.K. 1988: Enalapril: a second-generation angiotensin converting enzyme inhibitor American Journal of the Medical Sciences 296(5): 332-335
Zou, K.; Michikawa, M.; Komano, H. 2010: Novel Abeta-converting activity of angiotensin-converting enzyme and its role in Alzheimer's disease Seikagaku. Journal of Japanese Biochemical Society 82(12): 1120-1124